Amedeo Smart

Free Medical Literature Service

 

Amedeo

Malignant Melanoma
  Free Subscription

Articles published in
J Am Acad Dermatol
    May 2024
  1. FREEMAN SC, Paz Munoz E, Latour E, Lim JY, et al
    Response to Prieto et al., "RE: External validation of the Melanoma Institute Australia Sentinel Lymph Metastasis Risk Prediction Tool using the National Cancer Database".
    J Am Acad Dermatol. 2024 May 11:S0190-9622(24)00733.
    >> Share

  2. PRIETO PA, Goldberg MS, Martin B
    RE: External validation of the Melanoma Institute Australia Sentinel Lymph Metastasis Risk Prediction Tool using the National Cancer Database.
    J Am Acad Dermatol. 2024 May 9:S0190-9622(24)00735.
    >> Share

    April 2024
  3. KOGA S, Du W, Ono D
    Response to "Can ChatGPT Vision Diagnose Melanoma? An Exploratory Diagnostic Accuracy Study.".
    J Am Acad Dermatol. 2024 Apr 27:S0190-9622(24)00671.
    >> Share

  4. DESAI AD, Ibrahim SJ, Samie FH
    Evaluating the benefit of immunotherapy for Stage III melanoma.
    J Am Acad Dermatol. 2024 Apr 27:S0190-9622(24)00679.
    >> Share

  5. MONNIER J, Gouabou Foahom AC, Serdi M, Collenne J, et al
    Automated melanoma detection. An algorithm inspired from human intelligence characterizing disordered pattern of melanocytic lesions improving a convolutional neural network.
    J Am Acad Dermatol. 2024 Apr 11:S0190-9622(24)00630.
    >> Share

  6. WANG E, Ahad T, Liu YA, Lee TK, et al
    Incidence and profile of skin cancers in patients following ultraviolet phototherapy without psoralens: A retrospective cohort study.
    J Am Acad Dermatol. 2024;90:759-766.
    >> Share

  7. COHEN Y, Jaberi M, Litvinov IV, Shamout Y, et al
    Novel suturing technique for reduced electrocautery in excisional procedures for non-melanoma skin cancer.
    J Am Acad Dermatol. 2024;90:e131-e132.
    >> Share

    March 2024
  8. FUNCHAIN P, Ni Y, Heald B, Bungo B, et al
    Germline Cancer Susceptibility in Individuals with Melanoma.
    J Am Acad Dermatol. 2024 Mar 19:S0190-9622(24)00504.
    >> Share

  9. BANNER L, Rohan TZ, Zachian R, Gross T, et al
    Increased incidence of thyroid, renal, lung, melanoma, bladder, and prostate cancers after diagnosis of primary cutaneous B-cell lymphoma: A SEER database analysis.
    J Am Acad Dermatol. 2024 Mar 19:S0190-9622(24)00505.
    >> Share

  10. MATTHEWS NH, Hamad J, Henderson JB, Weinstock MA, et al
    Projected burden of melanoma clinical surveillance in the United States.
    J Am Acad Dermatol. 2024 Mar 8:S0190-9622(24)00476.
    >> Share

  11. TUPPER CJ, Clausen MC, Cogua LM, Silberstein PT, et al
    Improved Survival Outcomes for Melanoma of Unknown Primary in the Era of Novel Therapies: A Population-Based Retrospective Analysis.
    J Am Acad Dermatol. 2024 Mar 6:S0190-9622(24)00446.
    >> Share

  12. NEALE H, Plumptre I, Belazarian L, Wiss K, et al
    Guidance on screening magnetic resonance imaging decisions for congenital melanocytic nevi.
    J Am Acad Dermatol. 2024;90:e107-e108.
    >> Share

  13. GRANT-KELS JM
    JAAD Game Changer: Clinical and dermoscopic features of cutaneous BAP1-inactivated melanocytic tumors: Results of a multicenter case-control study by the International Dermoscopy Society.
    J Am Acad Dermatol. 2024;90:674.
    >> Share

    February 2024
  14. GIULINI M, Goldust M, Grabbe S, Ludwigs C, et al
    Combining artificial intelligence and human expertise for more accurate dermoscopic melanoma diagnosis: A 2-session retrospective reader study.
    J Am Acad Dermatol. 2024 Feb 29:S0190-9622(24)00307.
    >> Share

  15. TORTORELLO GN, Li EH, Sharon CE, Shafique N, et al
    Pathologic Characteristics and Clinical Outcomes of Primary Dermal Melanoma.
    J Am Acad Dermatol. 2024 Feb 22:S0190-9622(24)00401.
    >> Share

  16. HUANG Y, Fleming P, Fung K, Chan AW, et al
    Association between dermatology follow-up and melanoma survival: a population-based cohort study.
    J Am Acad Dermatol. 2024 Feb 16:S0190-9622(24)00372.
    >> Share

  17. MORR C, Jade Prechtel T, Hardacker R, Bell M, et al
    Impact of skin cancer screening on melanoma thickness and stage.
    J Am Acad Dermatol. 2024 Feb 13:S0190-9622(24)00348.
    >> Share

  18. KYE Y, Zhao G, Guhan S, Nunes D, et al
    Research letter: BRAF-inhibitor induced panniculitis - A systematic review.
    J Am Acad Dermatol. 2024;90:420-423.
    >> Share

    January 2024
  19. KOOPER-JOHNSON S, Kasthuri V, Homer A, Nguyen BM, et al
    Higher Risk of Melanoma-related Deaths for Patients Residing in Rural Counties: A Surveillance, Epidemiology, and End Results Program Study.
    J Am Acad Dermatol. 2024 Jan 31:S0190-9622(24)00167.
    >> Share

  20. CHOI ME, Jung JM, Kim DH, Won CH, et al
    Baseline Serum Neutrophil-to-Lymphocyte Ratio in Acral Melanoma Compared to Non-Acral Melanoma and its Prognostic Significance.
    J Am Acad Dermatol. 2024 Jan 23:S0190-9622(24)00103.
    >> Share

  21. TATE JA, Matsumoto A, Greif C, Lim J, et al
    Excision Margins for Melanoma in Situ on the Head and Neck - A Single-Center 10-year Retrospective Review of Treatment with Mohs Micrographic Surgery.
    J Am Acad Dermatol. 2024 Jan 20:S0190-9622(24)00102.
    >> Share

  22. SHIFAI N, van Doorn R, Malvehy J, Sangers T, et al
    Can ChatGPT Vision Diagnose Melanoma? An Exploratory Diagnostic Accuracy Study.
    J Am Acad Dermatol. 2024 Jan 18:S0190-9622(24)00076.
    >> Share

  23. VIKSTROM S, Syriopoulou E, Andersson TM, Eriksson H, et al
    Loss in life expectancy in Patients with Stage II-III cutaneous melanoma in Sweden: a population-based cohort study.
    J Am Acad Dermatol. 2024 Jan 11:S0190-9622(24)00056.
    >> Share

  24. TIMURKAYNAK O, Gonenli G
    Response to Young JN et al.'s "The utility of ChatGPT in generating patient-facing and clinical responses for melanoma".
    J Am Acad Dermatol. 2024 Jan 10:S0190-9622(24)00060.
    >> Share

  25. HEKLER A, Maron RC, Haggenmuller S, Schmitt M, et al
    Using Multiple Real-World Dermoscopic Photographs of One Lesion Improves Melanoma Classification via Deep Learning.
    J Am Acad Dermatol. 2024 Jan 8:S0190-9622(24)00048.
    >> Share

  26. NAVARRETE-DECHENT C, Jaimes N, Dusza SW, Liopyris K, et al
    Perifollicular linear projections: A dermatoscopic criterion for the diagnosis of lentigo maligna on the face.
    J Am Acad Dermatol. 2024;90:52-57.
    >> Share

    December 2023
  27. BERK-KRAUSS J, Sharma M, Polsky D, Geller AC, et al
    Cutaneous Melanoma Incidence - Evidence of a Flattening Curve.
    J Am Acad Dermatol. 2023 Dec 10:S0190-9622(23)03288.
    >> Share

  28. HAGSTROM M, Dhillon S, Fumero-Velazquez M, Olivares S, et al
    A reappraisal of the epidemiology of Spitz neoplasms in the molecular era: A retrospective cohort study.
    J Am Acad Dermatol. 2023;89:1185-1191.
    >> Share

  29. KOOPER-JOHNSON SB, Weber M, Eichtadt S, Nguyen BM, et al
    Limited commercialization of artificial intelligence technology in the diagnosis of pigmented lesions despite explosive growth in published programs.
    J Am Acad Dermatol. 2023;89:1246-1248.
    >> Share

  30. WAGNER NB, Knierim SM, Luttermann F, Metzler G, et al
    Histopathologic regression in patients with primary cutaneous melanoma undergoing sentinel lymph node biopsy is associated with favorable survival and, after metastasis, with improved progression-free survival on immune checkpoint inhibitor therapy: A
    J Am Acad Dermatol. 2023 Dec 1:S0190-9622(23)03250.
    >> Share

  31. FERNANDEZ JM, Mata EM, Plampton K, Whitley MJ, et al
    Melanoma Characteristics and Overall Survival Predictors in American Indians and Alaska Natives: An Analysis of the National Cancer Database from 2004 to 2018.
    J Am Acad Dermatol. 2023 Dec 1:S0190-9622(23)03254.
    >> Share

    November 2023
  32. FERNANDEZ JM, Evans TD, Schissel M, Siller A Jr, et al
    Racial and ethnic differences in time to definitive surgery for melanoma: A retrospective study from the National Cancer Database.
    J Am Acad Dermatol. 2023 Nov 30:S0190-9622(23)03251.
    >> Share

  33. PAN CX, Liu M, Lau CB, Lau WC, et al
    Histopathological predictors of immune-related adverse events among patients with melanoma treated with immune checkpoint inhibitors.
    J Am Acad Dermatol. 2023 Nov 29:S0190-9622(23)03239.
    >> Share

  34. HAWRYLUK EB, Moustafa D, Barry KK, Bahrani E, et al
    Risk Factors and Outcomes of Melanoma in Children and Adolescents: A Retrospective Multicenter Study.
    J Am Acad Dermatol. 2023 Nov 29:S0190-9622(23)03238.
    >> Share

  35. FALDETTA C, Kaleci S, Chester J, Ruini C, et al
    Melanoma clinicopathological groups characterized and compared with dermoscopy and reflectance confocal microscopy.
    J Am Acad Dermatol. 2023 Nov 19:S0190-9622(23)03014.
    >> Share

  36. MAGHFOUR J, Li P, Piontkowski A, Ozog D, et al
    Melanoma Incidence and Mortality: Exploring the Impact of Regional UV Radiation and Socioeconomic Status in the Context of Breslow Thickness.
    J Am Acad Dermatol. 2023 Nov 8:S0190-9622(23)03181.
    >> Share

  37. CLARK P, Howard H, Garrett E, Waters P, et al
    Health inequities in melanoma: A scoping review.
    J Am Acad Dermatol. 2023 Nov 2:S0190-9622(23)02892.
    >> Share

  38. KIM DY, Swetter SM, Huhmann L, Dizon MP, et al
    Real-world effectiveness of immune checkpoint inhibitors and BRAF/MEK inhibitors among Veteran cutaneous melanoma patients.
    J Am Acad Dermatol. 2023 Nov 2:S0190-9622(23)03089.
    >> Share

  39. TOMAS-VELAZQUEZ A, Lopez-Gutierrez JC, Reyes-Mugica M, Salgado CM, et al
    Serum levels of S-100 protein are directly proportional to the size, number, thickness and degree of cellularity of congenital melanocytic nevi.
    J Am Acad Dermatol. 2023;89:1074-1077.
    >> Share

  40. AHMED F, Fisher MJ, Snyder KM, Smith K, et al
    Adverse cutaneous reactions associated with MEK inhibitor therapy in a pediatric population.
    J Am Acad Dermatol. 2023;89:1066-1068.
    >> Share

  41. KIM DY, Christopher Dee E, Cheng I, Hartman RI, et al
    Advanced melanoma presentation and disease-specific survival disparities among disaggregated Asian American, Native Hawaiian, and Pacific Islander populations.
    J Am Acad Dermatol. 2023 Nov 1:S0190-9622(23)03090.
    >> Share

    October 2023
  42. EVERDELL E, Shah H, Parisi R, Feustel PJ, et al
    Non-visibility of Suspicious Lesions by Patients Leads to Later Detection of Melanoma: A Retrospective Analysis.
    J Am Acad Dermatol. 2023 Oct 4:S0190-9622(23)02888.
    >> Share

  43. FERNANDEZ JM, Koblinski JE, Dahak S, Curiel-Lewandrowski C, et al
    Gender Differences in Pediatric and Adolescent Melanoma: A Retrospective Analysis of 4,645 Cases.
    J Am Acad Dermatol. 2023 Oct 4:S0190-9622(23)02866.
    >> Share

  44. WAN G, Leung BW, DeSimone MS, Nguyen N, et al
    Development and Validation of Time-to-Event Models to Predict Metastatic Recurrence of Localized Cutaneous Melanoma.
    J Am Acad Dermatol. 2023 Oct 3:S0190-9622(23)02881.
    >> Share

  45. YUMEEN S, Mirza FN, Mirza HN, Zogg CK, et al
    Malignant blue nevus: Characterization of US epidemiology and prognostic factors of a rare neoplasm with aggressive clinical course using the Surveillance, Epidemiology, and End Results Program database.
    J Am Acad Dermatol. 2023;89:843-846.
    >> Share

  46. KRENGEL S, Ott H, Waelchli R
    Recommendations for routine magnetic resonance imaging in children with congenital melanocytic nevi need revision Comment to Neale et al., J Am Acad Dermatol. 87(5):1060-1068.
    J Am Acad Dermatol. 2023;89:e153-e154.
    >> Share

    September 2023
  47. WEI AH, Fane LS, Tripathi R, Bordeaux JS, et al
    Differences in presentation of cutaneous melanoma among Asian American and Pacific Islander patients.
    J Am Acad Dermatol. 2023 Sep 26:S0190-9622(23)02868.
    >> Share

  48. WEI AH, Zheng DX, Cullison CR, Scott JF, et al
    Incidence and characteristics of acral lentiginous melanoma in Asian Americans and Pacific Islanders.
    J Am Acad Dermatol. 2023 Sep 19:S0190-9622(23)02828.
    >> Share

  49. TAN SX, Aung TN, Claeson M, Acs B, et al
    Automated scoring of tumour infiltrating lymphocytes informs risk of death from thin melanoma: a nested case-case study.
    J Am Acad Dermatol. 2023 Sep 18:S0190-9622(23)02833.
    >> Share

  50. NI Y, Watts CG, Scolyer RA, Madronio C, et al
    Prognosis for people with multiple primary melanomas compared with a single primary melanoma.
    J Am Acad Dermatol. 2023 Sep 13:S0190-9622(23)02693.
    >> Share

  51. WU Q, Pan J, Lin W, Zhao S, et al
    Clinicopathologic features, delayed diagnosis and survival in amelanotic acral melanoma: a comparative study with pigmented melanoma.
    J Am Acad Dermatol. 2023 Sep 8:S0190-9622(23)02677.
    >> Share

  52. LIN JY, Wang J, Mishra K, Osmani S, et al
    Non-Melanoma Skin Cancer in Skin of Color Solid Organ Transplant Recipients.
    J Am Acad Dermatol. 2023 Sep 7:S0190-9622(23)02678.
    >> Share

  53. GRANT-KELS JM
    JAAD Game Changers: Poor prognosis for thin ulcerated melanomas and implications for a more aggressive approach to treatment.
    J Am Acad Dermatol. 2023 Sep 7:S0190-9622(23)02674.
    >> Share

  54. JILANI S, D'Amiano NM, Thompson KG, Ellis J, et al
    Factors Affecting Follow-Up Adherence Following Mohs Micrographic Surgery in Patients with Non-Melanoma Skin Cancer: A Retrospective Chart Review.
    J Am Acad Dermatol. 2023 Sep 5:S0190-9622(23)02669.
    >> Share

  55. KIM U, Hoehn R, Schwartz GK, Cullen J, et al
    Evaluating disruptions in melanoma diagnosis resulting from the COVID-19 pandemic from a community-based perspective.
    J Am Acad Dermatol. 2023 Sep 2:S0190-9622(23)02659.
    >> Share

  56. COSTELLO CM, Dusza SW, Marghoob AA, Halpern AC, et al
    Melanoma Screening and Public Education for Minority Populations in the United States.
    J Am Acad Dermatol. 2023 Sep 2:S0190-9622(23)02663.
    >> Share

  57. ANVERY N, Kang B, Christensen RE, Dirr MA, et al
    Minimum thresholds deemed acceptable by patients and physicians for sensitivity and specificity of mobile skin cancer screening algorithms.
    J Am Acad Dermatol. 2023;89:595-597.
    >> Share

  58. CHOI S, Mulvaney P
    Evaluating the landscape of discount and patient assistance programs for topical sunscreen products in the United States.
    J Am Acad Dermatol. 2023;89:580-582.
    >> Share

    August 2023
  59. SORENSEN R
    Impact of scalp location on survival in head and neck melanoma: A retrospective cohort study.
    J Am Acad Dermatol. 2023 Aug 26:S0190-9622(23)02633.
    >> Share

  60. XIONG DD, Bordeaux J
    The impact of the COVID-19 pandemic in 2020 on the diagnosis, treatment, and outcomes of invasive cutaneous melanoma: a retrospective national cohort study.
    J Am Acad Dermatol. 2023 Aug 23:S0190-9622(23)02595.
    >> Share

  61. BRODELL RT
    Primary dermal melanoma: A unique subtype of melanoma to be distinguished from cutaneous metastatic melanoma: A clinical, histologic, and gene expression-profiling study.
    J Am Acad Dermatol. 2023 Aug 16:S0190-9622(23)02515.
    >> Share

  62. ROSTER K, Rajeh A, Wu F, Wan G, et al
    Recurrence and Survival in Early-stage Acral Lentiginous Melanoma, A Retrospective Analysis.
    J Am Acad Dermatol. 2023 Aug 13:S0190-9622(23)02494.
    >> Share

  63. PAN CX, Lau WC, Kim DY, Lau CB, et al
    Association between baseline lactate dehydrogenase and immune-related adverse events among patients with melanoma varies by tumor stage at immune checkpoint inhibitor initiation.
    J Am Acad Dermatol. 2023 Aug 8:S0190-9622(23)02422.
    >> Share

  64. EL SHAROUNI MA, Lo SN, Scolyer RA, van Gils CH, et al
    Reply to: "Estrogen could also play a key role in the development of pediatric melanoma".
    J Am Acad Dermatol. 2023;89:e97-e98.
    >> Share

    July 2023
  65. AMARAL T, Pop OT, Chatziioannou E, Sinnberg T, et al
    EGFR expression is associated with relapse in a melanoma cohort receiving adjuvant PD-1-based immunotherapy.
    J Am Acad Dermatol. 2023 Jul 22:S0190-9622(23)02392.
    >> Share

  66. FREEMAN SC, Munoz EP, Latour E, Lim JY, et al
    External validation of the Melanoma Institute Australia Sentinel Node Metastasis Risk Prediction Tool using the National Cancer Database.
    J Am Acad Dermatol. 2023 Jul 14:S0190-9622(23)01350.
    >> Share

  67. HOANG MP, Karpinski P, Zuniga-Castillo M, Foreman RK, et al
    Histologic Margin Status is a Predictor of Relapse in Lentigo Maligna Melanoma.
    J Am Acad Dermatol. 2023 Jul 14:S0190-9622(23)01349.
    >> Share

  68. UGWU N, Cheraghlou S, Weiss J
    Primary Merkel Cell Carcinoma Is Associated with Increased, Extended Risk of Subsequent Melanoma and Non-Epithelial Skin Cancer.
    J Am Acad Dermatol. 2023 Jul 12:S0190-9622(23)01345.
    >> Share

  69. FERNANDEZ JM, Mata EM, Bubic BN, Kwan KR, et al
    Racial and ethnic differences in males with melanoma: A retrospective cohort study of 205,125 cases from the National Cancer Database.
    J Am Acad Dermatol. 2023 Jul 11:S0190-9622(23)01105.
    >> Share

  70. MUNOZ EP, Patel SP, Leachman SA, Yu NY, et al
    Minority Enrollment in Melanoma Clinical Trials.
    J Am Acad Dermatol. 2023 Jul 5:S0190-9622(23)01263.
    >> Share

  71. MEVES A, Todd A, Johnson EF
    Tumor width and calculated tumor area do not outperform Breslow thickness in predicting sentinel lymph node biopsy positivity.
    J Am Acad Dermatol. 2023;89:188-190.
    >> Share

  72. SMITH B, Smith JE, Demanelis K, Ferris LK, et al
    Changes in skin cancer screening rates in the United States from 2005 to 2015.
    J Am Acad Dermatol. 2023;89:142-145.
    >> Share

  73. MORGAN FC, Yehia L, McDonald C, Martinez-Agosto JA, et al
    Characterizing dermatologic findings among patients with PTEN hamartoma tumor syndrome: Results of a multicenter cohort study.
    J Am Acad Dermatol. 2023;89:90-98.
    >> Share

    June 2023
  74. INGRASSIA JP, Adotama P, Stein JA, Polsky D, et al
    Re-examining melanoma secondary prevention and the role of skin self-examination.
    J Am Acad Dermatol. 2023 Jun 27:S0190-9622(23)01195.
    >> Share

  75. RYPKA KJ, Goldfarb N, Mansh M
    Response to the Feasibility of Kreher et al.'s "Risk of melanoma and nonmelanoma skin cancer with immunosuppressants, part II: Methotrexate, alkylating agents, biologics, and small molecule inhibitors".
    J Am Acad Dermatol. 2023 Jun 26:S0190-9622(23)01188.
    >> Share

  76. PAN CX, Nambudiri VE
    Response to: "Response to Pan et al.'s 'Non-melanoma skin cancer in patients with hereditary hemochromatosis: a case-control study.'".
    J Am Acad Dermatol. 2023 Jun 12:S0190-9622(23)01099.
    >> Share

  77. BARRY R, Murray G, Hazel K, Ryan J, et al
    Response to Pan et al.'s "Non-melanoma skin cancer in patients with hereditary hemochromatosis: a case-control study.".
    J Am Acad Dermatol. 2023 Jun 12:S0190-9622(23)01100.
    >> Share

  78. ABRANTES T, Robbins A, Kahn B, Yumeen S, et al
    Understanding melanoma in situ - lentigo maligna surgical treatment terminology and guideline adherence, a targeted review.
    J Am Acad Dermatol. 2023 Jun 10:S0190-9622(23)01084.
    >> Share

  79. CHANG ALS, Zaba L, Kwong BY
    Immunotherapy for keratinocyte cancers. Part II: Identification and management of cutaneous side effects of immunotherapy treatments.
    J Am Acad Dermatol. 2023;88:1243-1255.
    >> Share

  80. LEUNG BW, Wan G, Nguyen N, Rashdan H, et al
    Increased risk of cutaneous immune-related adverse events in patients treated with talimogene laherparepvec and immune checkpoint inhibitors: A multi-hospital cohort study.
    J Am Acad Dermatol. 2023;88:1265-1270.
    >> Share

    May 2023
  81. LIM RK, Weinstock MA
    Racial disparities in diagnosis of invasive melanoma among veterans: A comparative analysis with the Surveillance, Epidemiology, and End Results Program.
    J Am Acad Dermatol. 2023 May 29:S0190-9622(23)00985.
    >> Share

  82. RAJEH A, Wan G, Roster K, Rashdan H, et al
    Underuse of sentinel lymph node biopsy for early-stage melanoma.
    J Am Acad Dermatol. 2023 May 25:S0190-9622(23)00975.
    >> Share

  83. KO MJ, Tsai WC, Tsai PH, Hsu LY, et al
    Ultraviolet B Phototherapy Does Not Increase the Risk of Skin Cancer Among Patients with Atopic Dermatitis: A Population-Based Retrospective Cohort Study.
    J Am Acad Dermatol. 2023 May 24:S0190-9622(23)00977.
    >> Share

  84. HEERFORDT IM, Philipsen PA, Andersen JD, Langhans L, et al
    RNA analysis of tape strips to rule out melanoma in lesions clinically assessed as cutaneous malignant melanoma: A diagnostic study.
    J Am Acad Dermatol. 2023 May 22:S0190-9622(23)00971.
    >> Share

  85. FANE LS, Wei AH, Tripathi R, Bordeaux JS, et al
    Asian American and Pacific Islander patients with melanoma have increased odds of treatment delays: a cross-sectional study.
    J Am Acad Dermatol. 2023 May 22:S0190-9622(23)00969.
    >> Share

  86. KIM DY, Marchetti MA, Hartman RI
    Differences in thickness-specific incidence of cutaneous melanoma by county type in the United States, 2010-2019.
    J Am Acad Dermatol. 2023 May 17:S0190-9622(23)00905.
    >> Share

  87. YOUNG JN, O'Hagan R, Poplausky D, Levoska MA, et al
    The utility of ChatGPT in generating patient-facing and clinical responses for melanoma.
    J Am Acad Dermatol. 2023 May 17:S0190-9622(23)00908.
    >> Share

  88. ZHANG S, Tang K, Wan G, Nguyen N, et al
    Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: A multi-institutional cohort study.
    J Am Acad Dermatol. 2023;88:1024-1032.
    >> Share

  89. JOEL MZ, Tripathi R, Scott JF
    Predictors of receipt of sentinel lymph node biopsy in patients with malignant adnexal tumors of the skin.
    J Am Acad Dermatol. 2023;88:1179-1182.
    >> Share

  90. FELMINGHAM C, Pan Y, Kok Y, Kelly J, et al
    Improving skin cancer management with ARTificial intelligence: A pre-post intervention trial of an artificial intelligence system used as a diagnostic aid for skin cancer management in a real-world specialist dermatology setting.
    J Am Acad Dermatol. 2023;88:1138-1142.
    >> Share

  91. SHI K, Zhang B, Kong BY, Zhang Y, et al
    Distinct genomic features in a retrospective cohort of mucosal, acral, and vulvovaginal melanomas.
    J Am Acad Dermatol. 2023;88:1051-1059.
    >> Share

  92. CAI ED, Swetter SM, Sarin KY
    Association of multiple primary melanomas with malignancy risk: A population-based analysis of entries from the Surveillance, Epidemiology, and End Results program database during 1973-2014.
    J Am Acad Dermatol. 2023;88:e211-e219.
    >> Share

    April 2023
  93. AZOULAY L, St-Jean A, Dahl M, Quail J, et al
    Hydrochlorothiazide use and risk of keratinocyte carcinoma and melanoma: A multi-site population-based cohort study.
    J Am Acad Dermatol. 2023 Apr 25:S0190-9622(23)00735.
    >> Share

  94. SHANNON AB, Karakousis GC
    The impact of the COVID-19 pandemic on new diagnoses of melanoma: a response to additional multi-institution and international reports.
    J Am Acad Dermatol. 2023 Apr 22:S0190-9622(23)00732.
    >> Share

  95. DRUMM C, Griffin C, Van Baarsel S, Quigley C, et al
    Response to Trepanowski et al.'s "Delays in melanoma presentation during the COVID-19 pandemic: a nationwide multi-institutional cohort study".
    J Am Acad Dermatol. 2023 Apr 21:S0190-9622(23)00733.
    >> Share

  96. CHOI ME, Yang HJ, Won CH, Chang SE, et al
    Differences in the Tumor Immunity-related Gene Expression Profile Between Acral Lentiginous and Non-acral Melanoma.
    J Am Acad Dermatol. 2023 Apr 19:S0190-9622(23)00712.
    >> Share

  97. FANE LS, Wei AH, Tripathi R, Bordeaux JS, et al
    Disparities between Asian groups in time to melanoma treatment: a cross-sectional study.
    J Am Acad Dermatol. 2023 Apr 11:S0190-9622(23)00589.
    >> Share

  98. HARVEY JA, Smith JF, Berry NA, Butterfield RJ, et al
    The influence of dermoscopy education over 14 years at a single institution: A retrospective cohort study.
    J Am Acad Dermatol. 2023;88:906-908.
    >> Share

    March 2023
  99. CRUM OM, Campbell EH, Reinhart JP, Proffer SL, et al
    Incidence Trends of Melanoma among Young Adults: An Epidemiologic Study in Olmsted County, Minnesota.
    J Am Acad Dermatol. 2023 Mar 29:S0190-9622(23)00518.
    >> Share

  100. MATA EM, Trinidad N, Blue E, Lobl M, et al
    Disparities in melanoma outcomes in urban versus rural settings: An analysis from the Nebraska Cancer Registry 2001-2016.
    J Am Acad Dermatol. 2023 Mar 20:S0190-9622(23)00450.
    >> Share

  101. MAGNATERRA E, Zuccaro B, Magliulo M, Venturi F, et al
    Estrogen could also play a key role in the development of pediatric melanoma.
    J Am Acad Dermatol. 2023 Mar 18:S0190-9622(23)00439.
    >> Share

  102. LIN EM, Lim RK, Lin S, Cho E, et al
    Disparities in Asian American Melanoma Diagnosis and Treatment from 1990-2014 -- Response to Zheng et al. "Poor melanoma outcomes and survival in Asian American and Pacific Islander patients".
    J Am Acad Dermatol. 2023 Mar 9:S0190-9622(23)00357.
    >> Share

  103. KIM DY, Behbahani S, Hartman RI
    Impact of COVID-19 pandemic on melanoma presentation by facility type and region in the United States.
    J Am Acad Dermatol. 2023 Mar 8:S0190-9622(23)00356.
    >> Share

  104. VERMARIEN-WANG J, Doeleman T, van Doorn R, Mooyaart AL, et al
    Ambiguous melanocytic lesions: A retrospective cohort study of incidence and outcome of melanocytic tumor of uncertain malignant potential (MELTUMP) and superficial atypical melanocytic proliferation of uncertain significance (SAMPUS) in the Netherlan
    J Am Acad Dermatol. 2023;88:602-608.
    >> Share

  105. TARANTINO IS, Kwak YJ, Goldberg LH, Beroukhim K, et al
    Application of a taped gauze on the gloved hand in preparation for a pressure bandage after a Mohs micrographic surgery layer.
    J Am Acad Dermatol. 2023;88:e125-e126.
    >> Share

  106. LEE K
    JAAD Game Changers *: The association of indoor tanning and melanoma in adults: Systematic review and meta-analysis.
    J Am Acad Dermatol. 2023;88:749.
    >> Share

    February 2023
  107. IQBAL A, Bell MC, Merkel EA, Somani AK, et al
    The effect of tumor mitotic rate on melanoma-specific survival: A SEER population-based study of 54,598 cases.
    J Am Acad Dermatol. 2023 Feb 23:S0190-9622(23)00274.
    >> Share

  108. NGUYEN N, Wan G, Ugwu-Dike P, Alexander NA, et al
    Influence of melanoma type on incidence and downstream implications of cutaneous immune-related adverse events in the setting of immune checkpoint inhibitor therapy.
    J Am Acad Dermatol. 2023 Feb 22:S0190-9622(23)00204.
    >> Share

  109. DESSINIOTI C, Plaka M, Kypreou K, Stergiopoulou A, et al
    A retrospective study of small-diameter invasive melanomas: metastasis at diagnosis and 9-year follow-up.
    J Am Acad Dermatol. 2023 Feb 21:S0190-9622(23)00267.
    >> Share

  110. STEPHENS MR, Asdourian MS, Jacoby TV, Shah N, et al
    Tumor-infiltrating lymphocytes as a predictive biomarker of cutaneous immune-related adverse events after immune checkpoint blockade in patients with advanced melanoma.
    J Am Acad Dermatol. 2023 Feb 15:S0190-9622(23)00193.
    >> Share

  111. WILSON BN, Shah R, Musthaq S, Vaidya T, et al
    Development of patient decision aids for the treatment of lentigo maligna and low-risk basal cell carcinoma.
    J Am Acad Dermatol. 2023;88:440-442.
    >> Share

  112. NAVARRETE-DECHENT C, Cordova M, Aleissa S, Liopyris K, et al
    Lentigo maligna melanoma mapping using reflectance confocal microscopy correlates with staged excision: A prospective study.
    J Am Acad Dermatol. 2023;88:371-379.
    >> Share

  113. LEE K
    JAAD Game Changers: Patterns of failure and predictors of outcome in cutaneous malignant melanoma of the scalp.
    J Am Acad Dermatol. 2023;88:517.
    >> Share

    January 2023
  114. YOUNG JN, Nguyen TA, Freeman SC, Hill E, et al
    Permanent section margin concordance after Mohs micrographic surgery with immunohistochemistry for invasive melanoma and melanoma in situ: a retrospective dual-center analysis.
    J Am Acad Dermatol. 2023 Jan 28:S0190-9622(23)00141.
    >> Share

  115. STULL CM, Nugent ST, Raj LK, Sobanko JF, et al
    Frequency and reliability of histologic subtype classification in invasive and in situ melanoma treated with Mohs micrographic surgery.
    J Am Acad Dermatol. 2023 Jan 17:S0190-9622(23)00082.
    >> Share

  116. BEAL BT, Udkoff J, Aizman L, Etzkorn J, et al
    Outcomes of invasive melanoma of the head and neck treated with Mohs Micrographic Surgery - a multicenter study.
    J Am Acad Dermatol. 2023 Jan 12:S0190-9622(23)00062.
    >> Share

  117. OH BH, Lee S, Park JW, Lee JY, et al
    Risk of recurrence of nail unit melanoma after functional surgery versus amputation.
    J Am Acad Dermatol. 2023 Jan 12:S0190-9622(23)00063.
    >> Share

  118. WOJCIK KY, Hawkins M, Anderson-Mellies A, Hall E, et al
    Melanoma Survival by Age Group: Population-Based Disparities for Adolescent and Young Adult Patients by Stage, Tumor Thickness, and Insurance Type.
    J Am Acad Dermatol. 2023 Jan 4:S0190-9622(23)00003.
    >> Share

  119. SPACCARELLI N, Drozdowski R, Peters MS, Grant-Kels JM, et al
    Dysplastic nevus part II: Dysplastic nevi: Molecular/genetic profiles and management.
    J Am Acad Dermatol. 2023;88:13-20.
    >> Share

  120. DROZDOWSKI R, Spaccarelli N, Peters MS, Grant-Kels JM, et al
    Dysplastic nevus part I: Historical perspective, classification, and epidemiology.
    J Am Acad Dermatol. 2023;88:1-10.
    >> Share

  121. FARIES MB, Cochran AJ, Thompson JF
    Re: "Time to reconsider the role of sentinel lymph node biopsy in melanoma".
    J Am Acad Dermatol. 2023;88:e25-e26.
    >> Share

  122. BEAULIEU D, Tsao H, Michaud DS, Okhovat JP, et al
    Factors associated with suspected nonmelanoma skin cancers, dysplastic nevus, and cutaneous melanoma among first-time SpotMe screening program participants during 2009-2010.
    J Am Acad Dermatol. 2023;88:60-70.
    >> Share

    December 2022
  123. VALEK SA, Rousseau MA, Nelson KC, Kannler C, et al
    Melanoma risk among career firefighters: A systematic review of case-control studies.
    J Am Acad Dermatol. 2022 Dec 30:S0190-9622(22)03320.
    >> Share

  124. ROUSSET P, Dalle S, Mortier L, Dereure O, et al
    Impact of systemic therapies in metastatic melanoma of unknown primary: A study from MELBASE, a French multicentric prospective cohort.
    J Am Acad Dermatol. 2022 Dec 19:S0190-9622(22)03142.
    >> Share

  125. HUERTA T, Swetter SM, Nehal KS, Coit DG, et al
    Current evidence does not support Mohs micrographic surgery or staged excision as equivalent to wide excision for primary cutaneous melanoma.
    J Am Acad Dermatol. 2022 Dec 16:S0190-9622(22)03308.
    >> Share

  126. PEDERSEN EA, Harms PW, Zhao L, Andea AA, et al
    Polypoid melanoma is associated with aggressive histopathological characteristics and poor clinical prognosis: A retrospective cohort study.
    J Am Acad Dermatol. 2022 Dec 10:S0190-9622(22)03181.
    >> Share

  127. EL SHAROUNI MA, Rawson RV, Potter AJ, Paver EC, et al
    Melanomas in children and adolescents: clinicopathologic features and survival outcomes.
    J Am Acad Dermatol. 2022 Dec 9:S0190-9622(22)03176.
    >> Share

    November 2022
  128. KREHER MA, Noland MMB, Konda S, Longo MI, et al
    Risk of melanoma and nonmelanoma skin cancer with immunosuppressants Part I: Calcineurin inhibitors, thiopurines, IMDH inhibitors, mTOR inhibitors, and corticosteroids.
    J Am Acad Dermatol. 2022 Nov 29:S0190-9622(22)03145.
    >> Share

  129. KREHER MA, Konda S, Noland MMB, Longo MI, et al
    Risk of melanoma and nonmelanoma skin cancer with immunosuppressants Part II: Methotrexate, alkylating agents, biologics, and small molecule inhibitors.
    J Am Acad Dermatol. 2022 Nov 29:S0190-9622(22)03146.
    >> Share

  130. SHARON CE, Straker RJ 3rd, Gimotty PA, Chu EY, et al
    Sentinel lymph node biopsy status improves adjuvant therapy decision-making in patients with clinical stage IIB/C melanoma: a population-based analysis.
    J Am Acad Dermatol. 2022 Nov 25:S0190-9622(22)03133.
    >> Share

  131. KNACKSTEDT T
    Differences in Sentinel Lymph Node Biopsy Utilization in Eligible Melanoma Patients Treated with Mohs Micrographic Surgery or Wide Local Excision: A population-based logistic regression model and survival analysis.
    J Am Acad Dermatol. 2022 Nov 8. pii: S0190-9622(22)02988.
    >> Share

  132. VAN MOLLE P, Brochez L, Verbelen T, De Boom C, et al
    The value of measuring uncertainty in neural networks in dermoscopy.
    J Am Acad Dermatol. 2022;87:1191-1193.
    >> Share

  133. SEIVERLING EV, Stevens K, Dorr G, Prentiss MA, et al
    Impact of multimodal dermatoscopy training on skin biopsies by primary care providers.
    J Am Acad Dermatol. 2022;87:1119-1121.
    >> Share

    October 2022
  134. ROTH A, Boutko A, Lampley N 3rd, Olivares S, et al
    Indoor tanning is associated with an increased risk for multiple primary melanomas: A case-control study.
    J Am Acad Dermatol. 2022 Oct 30. pii: S0190-9622(22)02781.
    >> Share

  135. RIQUELME-MC LOUGHLIN C, Sandoval-Clavijo A, de Tord MB, Boada A, et al
    Prognostic role of microsatellites in melanoma and implications in the AJCC classification system: a cohort study.
    J Am Acad Dermatol. 2022 Oct 17. pii: S0190-9622(22)02898.
    >> Share

  136. FERNANDEZ JM, Dahak S, Wysong A, Whitley MJ, et al
    Differences Between Asian Americans and Pacific Islanders with Cutaneous Melanoma: A Retrospective Cohort Analysis of 1,339 Cases.
    J Am Acad Dermatol. 2022 Oct 13. pii: S0190-9622(22)02887.
    >> Share

  137. FERNANDEZ JM, Mata EM, Behbahani S, Kwan KR, et al
    Survival of Hispanic Patients with Cutaneous Melanoma: A Retrospective Cohort Analysis of 6,016 Cases from the National Cancer Database.
    J Am Acad Dermatol. 2022 Oct 10. pii: S0190-9622(22)02806.
    >> Share

  138. ROSENTHAL A, Reddy S, Cooper R, Chung J, et al
    Disparities in Melanoma-Specific Mortality by Race/Ethnicity, Socioeconomic Status, and Healthcare Systems.
    J Am Acad Dermatol. 2022 Oct 10. pii: S0190-9622(22)02800.
    >> Share

  139. LEE DK, Chang MJ, Desai AD, Lipner SR, et al
    Clinical and dermoscopic findings of benign longitudinal melanonychia due to melanocytic activation differ by skin type and predict likelihood of nail matrix biopsy.
    J Am Acad Dermatol. 2022;87:792-799.
    >> Share

  140. JAIN M, Autuori I, Everett N, Harris U, et al
    Minimally invasive microbiopsy for genetic profiling of melanocytic lesions: A case series.
    J Am Acad Dermatol. 2022;87:903-904.
    >> Share

  141. DELLATORRE G, Gadens GA, Polo Silveira L, Kose K, et al
    Video-based wide area digital dermoscopy.
    J Am Acad Dermatol. 2022;87:e125-e126.
    >> Share

    September 2022
  142. SHANNON AB, Sharon CE, Straker RJ 3rd, Carr MJ, et al
    Sentinel Lymph Node Biopsy in Patients with T1a Cutaneous Malignant Melanoma: A Multi-Center Cohort Study.
    J Am Acad Dermatol. 2022 Sep 29. pii: S0190-9622(22)02783.
    >> Share


  143. The association between COVID-19 lockdowns and melanoma diagnosis and thickness: A multicenter retrospective study from Europe.
    J Am Acad Dermatol. 2022 Sep 24. pii: S0190-9622(22)02780.
    >> Share

  144. WEI X, Chen Y, Yao H, Wu D, et al
    Prognostic impact of Breslow thickness in acral melanoma: A retrospective analysis.
    J Am Acad Dermatol. 2022 Sep 5. pii: S0190-9622(22)02627.
    >> Share

  145. KIM CG, Kim M, Hwang J, Kim ST, et al
    First-line pembrolizumab versus dabrafenib/trametinib treatment for BRAF V600-mutant advanced melanoma.
    J Am Acad Dermatol. 2022 Sep 3. pii: S0190-9622(22)02443.
    >> Share

  146. PHAM F, Boespflug A, Duru G, Phan A, et al
    Dermatoscopic and clinical features of congenital or congenital-type nail matrix nevi: A multicenter prospective cohort study by the International Dermoscopy Society.
    J Am Acad Dermatol. 2022;87:551-558.
    >> Share

  147. PHAM JP, Star P, Phan K, Loh Y, et al
    BRAF inhibition and the spectrum of granulomatous reactions.
    J Am Acad Dermatol. 2022;87:605-613.
    >> Share

    August 2022
  148. FALOTICO JM, Postow MA, Lipner SR
    Standardized guidelines for acral and nail unit melanoma treatment are lacking.
    J Am Acad Dermatol. 2022 Aug 18. pii: S0190-9622(22)02548.
    >> Share

  149. CHERAGHLOU S, Doudican NA, Criscito MC, Stevenson ML, et al
    Assessing rates of compliance with national guidelines regarding sentinel lymph node biopsy for invasive melanomas treated with Mohs micrographic surgery.
    J Am Acad Dermatol. 2022 Aug 17. pii: S0190-9622(22)02544.
    >> Share

  150. KOLLA AM, Seixas A, Adotama P, Foster V, et al
    A Health Equity Framework to Address Racial and Ethnic Disparities in Melanoma.
    J Am Acad Dermatol. 2022 Aug 12. pii: S0190-9622(22)02526.
    >> Share

  151. RAN NA, Nugent ST, Veerabagu S, Chu EY, et al
    Desmoplastic melanoma treated with wide local excision or Mohs micrographic surgery - rates of positive margins, local recurrence, and repeat surgeries.
    J Am Acad Dermatol. 2022 Aug 10. pii: S0190-9622(22)02450.
    >> Share

  152. FERNANDEZ JM, Bubic BN, Dahak S, Mata EM, et al
    Racial and Ethnic Differences in Tumor Characteristics and Overall Survival of Women with Melanoma: A National Cancer Database Retrospective Cohort Study.
    J Am Acad Dermatol. 2022 Aug 3. pii: S0190-9622(22)02413.
    >> Share

  153. MARCAILLOU M, Dion J, Baroudjian B, Ezrine E, et al
    Sample CME manuscript submission: Response to the article by Pham et al entitled "Review BRAF inhibition and the spectrum of granulomatous reactions".
    J Am Acad Dermatol. 2022;87:e85-e88.
    >> Share

  154. LEE JS, Kim S, Kim DH, Lee JW, et al
    Clinical features and natural course of pediatric longitudinal melanonychia: A retrospective cohort study in Korea.
    J Am Acad Dermatol. 2022;87:366-372.
    >> Share

  155. PEREZ M, Abisaad JA, Rojas KD, Marchetti MA, et al
    Skin cancer: Primary, secondary, and tertiary prevention. Part I.
    J Am Acad Dermatol. 2022;87:255-268.
    >> Share

    July 2022
  156. PAN CX, Yang K, Lau CB, Zhou G, et al
    Non-melanoma skin cancer in patients with hereditary hemochromatosis: a case-control study.
    J Am Acad Dermatol. 2022 Jul 21. pii: S0190-9622(22)02400.
    >> Share

  157. JARELL A, Gastman BR, Dillon LD, Hsueh EC, et al
    Optimizing treatment approaches for patients with cutaneous melanoma by integrating clinical and pathologic features with the 31-gene expression profile test.
    J Am Acad Dermatol. 2022 Jul 7. pii: S0190-9622(22)02253.
    >> Share

  158. MULLIGAN KM, Cullison CR, Zheng DX, Rothermel LD, et al
    Mucosal melanoma and organ-specific metastasis: Differences in survival outcomes between tumor primary sites.
    J Am Acad Dermatol. 2022 Jul 5. pii: S0190-9622(22)02248.
    >> Share

  159. XIONG DD, Barriera-Silvestrini P, Knackstedt TJ
    Delays in surgical treatment of melanoma are associated with worsened overall and melanoma-specific mortality: a population-based analysis.
    J Am Acad Dermatol. 2022 Jul 1. pii: S0190-9622(22)02239.
    >> Share

    June 2022
  160. TREPANOWSKI N, Chang MS, Zhou G, Ahmad M, et al
    Delays in melanoma presentation during the COVID-19 pandemic: a nationwide multi-institutional cohort study.
    J Am Acad Dermatol. 2022 Jun 20. pii: S0190-9622(22)01023.
    >> Share

  161. CHOI ME, Won CH, Chang SE, Lee MW, et al
    Clinical and Prognostic Influence of Tumor Diameter in Acral Lentiginous Melanoma.
    J Am Acad Dermatol. 2022 Jun 17. pii: S0190-9622(22)01019.
    >> Share

  162. ELSTON DM
    Letter from the editor: Delays in Melanoma Diagnosis.
    J Am Acad Dermatol. 2022 Jun 16. pii: S0190-9622(22)01011.
    >> Share

  163. KUMAR AB, Peters MS, Jakub JW, Harmsen W, et al
    "Primary cutaneous melanoma features predict development of intransit metastases/satellite lesions: Mayo Clinic experience 2010-2014".
    J Am Acad Dermatol. 2022 Jun 13. pii: S0190-9622(22)00994.
    >> Share

  164. BLUMENTHAL LY, Hu JC
    Response to "Comment on 'Racial/Ethnic disparities in non-melanoma skin cancer based on Mohs micrographic surgery defect size, a multicenter retrospective study'".
    J Am Acad Dermatol. 2022 Jun 2. pii: S0190-9622(22)00902.
    >> Share

    May 2022
  165. KURN HA, Abercrombie M, Tzellos T, Dellavalle RP, et al
    From the Cochrane Library: Interventions for Melanoma in Situ, Including Lentigo Maligna.
    J Am Acad Dermatol. 2022 May 28. pii: S0190-9622(22)00889.
    >> Share

  166. SCHARF C, Brancaccio G, Di Stefani A, Fargnoli MC, et al
    THE ASSOCIATION BETWEEN LOCKDOWNS DURING THE COVID-19 PANDEMIC AND MELANOMA DIAGNOSIS: A MULTICENTER RETROSPECTIVE STUDY FROM EUROPE.
    J Am Acad Dermatol. 2022 May 16. pii: S0190-9622(22)00812.
    >> Share

  167. LUU YT, Goldstein AM, Sargen MR
    Variation in second cancer risk by melanoma subtype among survivors.
    J Am Acad Dermatol. 2022 May 16. pii: S0190-9622(22)00816.
    >> Share

  168. SHAIKH SS, Yang X, Fortman DD, Wang H, et al
    A Retrospective Analysis of the Impact of the COVID-19 Pandemic on Staging at Presentation of Patients with Invasive Melanoma.
    J Am Acad Dermatol. 2022 May 9. pii: S0190-9622(22)00798.
    >> Share

  169. BRUNSGAARD E, Wu YP, Grossman D
    Melanoma in Skin of Color: Part I. Epidemiology and clinical presentation.
    J Am Acad Dermatol. 2022 May 6. pii: S0190-9622(22)00783.
    >> Share

  170. BRUNSGAARD E, Jensen J, Grossman D
    Melanoma in Skin of Color: Part II. Racial disparities, role of UV, and interventions for earlier detection.
    J Am Acad Dermatol. 2022 May 6. pii: S0190-9622(22)00784.
    >> Share

  171. SARVER MM, Rames JD, Beasley GM, Gao J, et al
    Survival and Tumor Characteristics of Patients Presenting with Single Primary vs. Second Primary Melanoma Lesions.
    J Am Acad Dermatol. 2022 May 4. pii: S0190-9622(22)00715.
    >> Share

  172. CONDORELLI AG, Farnetani F, Ciardo S, Chester J, et al
    Dynamic dermoscopic and reflectance confocal microscopic changes of melanocytic lesions excised during follow up.
    J Am Acad Dermatol. 2022;86:1049-1057.
    >> Share

  173. SOENEN A, Vourc'h M, Khammari A, Nguyen JM, et al
    Change in lentigo maligna score assessed by in vivo reflectance confocal microscopy after 1 month of imiquimod treatment for lentigo maligna management.
    J Am Acad Dermatol. 2022;86:1042-1048.
    >> Share

    April 2022
  174. MORAES AFA, Blumetti TCMP, Pinto C, Bertoli E, et al
    Melanoma with peripheral globules: clinical and dermoscopic features.
    J Am Acad Dermatol. 2022 Apr 26. pii: S0190-9622(22)00697.
    >> Share

  175. STRAKER RJ 3RD, Sharon CE, Chu EY, Miura JT, et al
    Sentinel lymph node biopsy in patients with clinical stage IIB/C cutaneous melanoma: A national cohort study.
    J Am Acad Dermatol. 2022 Apr 22. pii: S0190-9622(22)00681.
    >> Share

    March 2022
  176. HOBAYAN CGP, Grant-Kels JM, Korman AM
    The ethics of dismissing a melanoma patient who repeatedly no-shows.
    J Am Acad Dermatol. 2022 Mar 19. pii: S0190-9622(22)00504.
    >> Share

  177. CHANG MS, La J, Trepanowski N, Cheng D, et al
    Increased relative proportions of advanced melanoma among Veterans: a comparative analysis with the SEER registry.
    J Am Acad Dermatol. 2022 Mar 9. pii: S0190-9622(22)00392.
    >> Share

  178. WONGVIBULSIN S, Pahalyants V, Kalinich M, Murphy W, et al
    Epidemiology and risk factors for the development of cutaneous toxicities in patients treated with immune-checkpoint inhibitors: A United States population-level analysis.
    J Am Acad Dermatol. 2022;86:563-572.
    >> Share

    February 2022
  179. ASDOURIAN MS, Otto TS, Jacoby TV, Shah N, et al
    Association between serum LDH and cutaneous immune-related adverse events among patients on immune checkpoint inhibitors for advanced melanoma.
    J Am Acad Dermatol. 2022 Feb 19. pii: S0190-9622(22)00335.
    >> Share

  180. EL SHAROUNI MA, Rawson RV, Sigurdsson V, Witkamp AJ, et al
    The progressive relationship between increasing Breslow thickness and decreasing survival is lost in patients with ultra-thick melanomas (>/=15mm in thickness).
    J Am Acad Dermatol. 2022 Feb 1. pii: S0190-9622(22)00174.
    >> Share

    January 2022
  181. PRASAD S, Black S, Chen HW, Joseph A, et al
    Beliefs and barriers to care of primary care practitioners towards melanoma screening and education in rural Texas.
    J Am Acad Dermatol. 2022 Jan 22. pii: S0190-9622(22)00091.
    >> Share

  182. MUZUMDAR S, Wu R, Rothe MJ, Grant-Kels JM, et al
    Reflectance confocal microscopy decreases the cost of skin lesion diagnosis: A single institution retrospective chart review.
    J Am Acad Dermatol. 2022;86:209-211.
    >> Share

    December 2021
  183. SKUDALSKI L, Waldman R, Kerr PE, Grant-Kels JM, et al
    Melanoma: How and When to Consider Clinical Diagnostic Technologies.
    J Am Acad Dermatol. 2021 Dec 13. pii: S0190-9622(21)02971.
    >> Share

  184. SKUDALSKI L, Waldman R, Kerr PE, Grant-Kels JM, et al
    Melanoma: An Update on Systemic Therapies.
    J Am Acad Dermatol. 2021 Dec 13. pii: S0190-9622(21)02970.
    >> Share

  185. GOLDSMITH SM
    Comment on "Clinicopathologic, misdiagnosis, and survival differences between clinically amelanotic melanomas and pigmented melanomas".
    J Am Acad Dermatol. 2021;85:e361.
    >> Share

  186. VASICEK B, Erickson T, Lake E
    Comment on "Descriptive survival study of nail melanoma patients treated with functional surgery versus distal amputation".
    J Am Acad Dermatol. 2021;85:e351.
    >> Share

  187. MONTAGNER S
    Reply to: "Comment on 'Descriptive survival study of nail melanoma patients treated with functional surgery versus distal amputation'".
    J Am Acad Dermatol. 2021;85:e353.
    >> Share

  188. OKHOVAT JP, Davine JA, Hawryluk EB, Geller AC, et al
    Educational brochure impact on postscreening practices of American Academy of Dermatology skin cancer screening participants.
    J Am Acad Dermatol. 2021;85:1616-1617.
    >> Share

  189. ZAKHEM GA, Fakhoury JW, Motosko CC, Ho RS, et al
    Characterizing the role of dermatologists in developing artificial intelligence for assessment of skin cancer.
    J Am Acad Dermatol. 2021;85:1544-1556.
    >> Share

    November 2021
  190. KURN HA, Sivesind TE, Dellavalle RP
    From the Cochrane Library: Screening for Reducing Morbidity and Mortality in Malignant Melanoma.
    J Am Acad Dermatol. 2021 Nov 25. pii: S0190-9622(21)02909.
    >> Share

  191. RAVAL NS, Hodges WT, Ugwu-Dike PO, Godoy F, et al
    Racial and socioeconomic differences in acral lentiginous melanoma outcomes: a SEER analysis.
    J Am Acad Dermatol. 2021 Nov 20. pii: S0190-9622(21)02856.
    >> Share

  192. THORPE RB, Covington KR, Caruso HG, Quick AP, et al
    Development and validation of a nomogram incorporating gene expression profiling and clinical factors for accurate prediction of metastasis in patients with cutaneous melanoma following Mohs micrographic surgery.
    J Am Acad Dermatol. 2021 Nov 19. pii: S0190-9622(21)02854.
    >> Share

  193. KANTOR J
    This Month in JAAD International: February 2022: Vitiligo in melanoma patients treated with anti-PD-1 therapies and improved survival.
    J Am Acad Dermatol. 2021 Nov 6. pii: S0190-9622(21)02749.
    >> Share

  194. SOENEN A, Vourc'h M, Dreno B, Chiaverini C, et al
    Diagnosis of congenital pigmented macules in infants with reflectance confocal microscopy and machine learning.
    J Am Acad Dermatol. 2021;85:1308-1309.
    >> Share

  195. MAZMUDAR RS, Fazio J, Garland K, Tripathi R, et al
    Predictors of patient-initiated communication after Mohs micrographic surgery: A multi-institutional prospective cohort study.
    J Am Acad Dermatol. 2021;85:1290-1293.
    >> Share

  196. GOMEZ-MARTIN I, Collgros H, Ferguson PM, Barreiro A, et al
    Diagnostic accuracy of pigmented labial macules by in vivo reflectance confocal microscopy and correlation among techniques.
    J Am Acad Dermatol. 2021;85:1151-1160.
    >> Share

  197. TRIPATHI R, Bordeaux JS, Nijhawan RI
    Utilization of palliative therapy for metastatic melanoma in the United States.
    J Am Acad Dermatol. 2021;85:1342-1345.
    >> Share

  198. CHANG MS, Huang L, Mostaghimi A, Hartman RI, et al
    Lifetime history of total body skin examinations in patients with disabilities: Examining for differences in skin cancer screening.
    J Am Acad Dermatol. 2021;85:1326-1328.
    >> Share

    October 2021
  199. FARAH M, Chung HJ
    Diagnostic Utility of PRAME Immunohistochemistry in the Evaluation of Melanomas with a Co-existent Nevoid Melanocytic Population: A Single Center Retrospective Cohort Study.
    J Am Acad Dermatol. 2021 Oct 28. pii: S0190-9622(21)02714.
    >> Share

  200. IPENBURG NA, El Sharouni MA, van Doorn R, van Diest PJ, et al
    Lack of association between CDKN2A germline mutations and survival in melanoma patients: a retrospective cohort study.
    J Am Acad Dermatol. 2021 Oct 22. pii: S0190-9622(21)02677.
    >> Share

  201. LIN JQ, Li SQ, Li S, Kiamanesh EF, et al
    A 10-year retrospective cohort study of ruxolitinib and association with non-melanoma skin cancer in polycythemia vera and myelofibrosis patients.
    J Am Acad Dermatol. 2021 Oct 11. pii: S0190-9622(21)02632.
    >> Share

  202. LITCHMAN GH, Teplitz RW, Marson JW, Rigel DS, et al
    Impact of electrical impedance spectroscopy on dermatologists' number needed to biopsy metric and biopsy decisions for pigmented skin lesions.
    J Am Acad Dermatol. 2021;85:976-979.
    >> Share

    September 2021
  203. GAGHAN LJ, Bui H, Lipner SR, Jellinek NJ, et al
    Evaluation of a community education tool for detection of nail melanoma by nail salon technicians.
    J Am Acad Dermatol. 2021 Sep 21. pii: S0190-9622(21)02503.
    >> Share

  204. BLUMENTHAL LY, Arzeno J, Syder N, Rabi S, et al
    Disparities in non-melanoma skin cancer in Hispanic/Latino patients based on Mohs micrographic surgery defect size, a multicenter retrospective study.
    J Am Acad Dermatol. 2021 Sep 4. pii: S0190-9622(21)02423.
    >> Share

  205. LALLAS A, Kyrgidis A, Manoli SM, Papageorgiou C, et al
    Delayed skin cancer diagnosis in 2020 because of the COVID-19-related restrictions: Data from an institutional registry.
    J Am Acad Dermatol. 2021;85:721-723.
    >> Share

    August 2021
  206. MCFEELY O, Hollywood A, Stanciu M, O'Connell M, et al
    Comment on "The Impact of the COVID-19 pandemic on the presentation status of newly diagnosed melanoma: a single institution experience".
    J Am Acad Dermatol. 2021 Aug 28. pii: S0190-9622(21)02383.
    >> Share

  207. STRAKER RJ 3RD, Kelly N, Sharon CE, Shannon AB, et al
    Local recurrence in patients undergoing wide excision and sentinel lymph node biopsy for cutaneous malignant melanoma: A single-center, retrospective cohort analysis.
    J Am Acad Dermatol. 2021 Aug 12. pii: S0190-9622(21)02299.
    >> Share

  208. YAN BY, Barilla S, Strunk A, Garg A, et al
    Survival Differences in Acral Lentiginous Melanoma According to Socioeconomic Status and Race.
    J Am Acad Dermatol. 2021 Aug 4. pii: S0190-9622(21)02210.
    >> Share

  209. PARISI R, Huppertz J, Potolski A, Tracey V, et al
    Distance to Diagnosing Dermatology Provider as a Predictor of Multiple Melanoma Diagnoses.
    J Am Acad Dermatol. 2021 Aug 3. pii: S0190-9622(21)02214.
    >> Share

  210. KANTOR J
    August 2021: On the epistemology of Breslow thickness and histopathologic melanoma subtype.
    J Am Acad Dermatol. 2021;85:318.
    >> Share

  211. WANG TS, Griffiths CC, Roman EM
    Should topical imiquimod be used for positive margins in lentigo maligna?
    J Am Acad Dermatol. 2021;85:521-522.
    >> Share

    July 2021
  212. GAUDY-MARQUESTE C, Macagno N, Loundou A, Pellegrino E, et al
    Molecular characterization of fast-growing melanomas.
    J Am Acad Dermatol. 2021 Jul 16. pii: S0190-9622(21)02101.
    >> Share

  213. BUI AN, Bougrine A, Buchbinder EI, Giobbie-Hurder A, et al
    Female sex is associated with higher rates of dermatologic adverse events among patients with melanoma receiving immune checkpoint inhibitor therapy: a retrospective cohort study.
    J Am Acad Dermatol. 2021 Jul 9. pii: S0190-9622(21)02087.
    >> Share

  214. STRAKER RJ 3RD, Thaler AS, Shannon AB, Miura JT, et al
    Acral lentiginous melanoma in the era of immune checkpoint blockade and targeted therapy: A National Cancer Database analysis.
    J Am Acad Dermatol. 2021 Jul 9. pii: S0190-9622(21)02095.
    >> Share

    June 2021
  215. YOO H, Kim H, Kwon ST, Jo SJ, et al
    Tumor invasion in the hyponychium is associated with distant metastasis and poor prognosis in subungual melanoma: A histological landscape of 44 cases.
    J Am Acad Dermatol. 2021 Jun 18. pii: S0190-9622(21)01989.
    >> Share

  216. CARLET C, Dalle S, Leccia MT, Mortier L, et al
    Late-onset adverse events under anti-PD1 therapy in melanoma patients: an observational study from MELBASE, a nationwide prospective cohort.
    J Am Acad Dermatol. 2021 Jun 18. pii: S0190-9622(21)01991.
    >> Share

  217. FIGUEROA-SILVA O, Suarez-Penaranda JM, Balboa-Barreiro V, Rojas SA, et al
    Volume tumor impact on melanoma survival assessed through Breslow density.
    J Am Acad Dermatol. 2021 Jun 8. pii: S0190-9622(21)01107.
    >> Share

  218. MUZUMDAR S, Lin G, Kerr P, Grant-Kels JM, et al
    Is Melanoma Overdiagnosed? A Review of the Evidence.
    J Am Acad Dermatol. 2021 Jun 8. pii: S0190-9622(21)01110.
    >> Share

  219. BEAULIEU D, Gao DX, Swetter SM, Hawryluk EB, et al
    Association between income and suspected non-melanoma and melanoma skin cancers among participants of the American Academy of Dermatology's SPOT Skin Cancer(R) screening program - A cross-sectional analysis.
    J Am Acad Dermatol. 2021 Jun 2. pii: S0190-9622(21)01044.
    >> Share

  220. VAIDYA TS, Bander TS, Musthaq S, Lampley N 3rd, et al
    Validation of a patient decision aid for the treatment of lentigo maligna.
    J Am Acad Dermatol. 2021;84:1751-1753.
    >> Share

  221. HANLON KL, Correa-Selm LM, Grichnik JM
    Application of 3-dimensional reflectance confocal microscopy: Melanocytic proliferations as three-dimensional models.
    J Am Acad Dermatol. 2021;84:1737-1739.
    >> Share

  222. ELSTON D
    This Month in JAAD: June 2021.
    J Am Acad Dermatol. 2021;84:1542.
    >> Share

  223. LONGO C, Mazzeo M, Raucci M, Cornacchia L, et al
    Dark pigmented lesions: Diagnostic accuracy of dermoscopy and reflectance confocal microscopy in a tertiary referral center for skin cancer diagnosis.
    J Am Acad Dermatol. 2021;84:1568-1574.
    >> Share

    May 2021
  224. GREEN AC, Hughes MCB, Williams GM, Malt M, et al
    Increased melanoma recurrence in patients with multiple primary invasive melanomas.
    J Am Acad Dermatol. 2021 May 27. pii: S0190-9622(21)01012.
    >> Share

  225. BITTAR PG, Bittar JM, Etzkorn JR, Brewer JD, et al
    Systematic Review and Meta-Analysis of Local Recurrence Rates of Head and Neck Cutaneous Melanomas after Wide Local Excision, Mohs Micrographic Surgery, or Staged Excision.
    J Am Acad Dermatol. 2021 May 4. pii: S0190-9622(21)00937.
    >> Share

  226. CHANG MS, Hartman RI
    Melanoma healthcare and outcome disparities in the Veteran Affairs population.
    J Am Acad Dermatol. 2021 May 4. pii: S0190-9622(21)00938.
    >> Share

    April 2021
  227. DUNCAN JR, Srikakolapu S, Daugherty A, Elston C, et al
    Cost Efficacy of Wide Local Excision of pT1a Melanoma in Office vs. Operating Room Settings.
    J Am Acad Dermatol. 2021 Apr 28. pii: S0190-9622(21)00920.
    >> Share

  228. GRANT-KELS JM
    JAAD Game Changers: Comparison of surgical margins for lentigo maligna versus melanoma in situ.
    J Am Acad Dermatol. 2021 Apr 21. pii: S0190-9622(21)00887.
    >> Share

  229. MILLER CJ, Etzkorn JR, Leitenberger JJ, Bar A, et al
    Commentary on "Limitations in the literature regarding Mohs surgery and staged excision for melanoma: A critical review of quality and data reporting".
    J Am Acad Dermatol. 2021 Apr 16. pii: S0190-9622(21)00770.
    >> Share

  230. ADALSTEINSSON JA, Stoj VJ, Algzlan H, Swede H, et al
    Limitations in the Literature Regarding Mohs Surgery and Staged Excision for Melanoma: A Critical Review of Quality and Data Reporting.
    J Am Acad Dermatol. 2021 Apr 16. pii: S0190-9622(21)00772.
    >> Share

  231. AGGARWAL P, Knabel P, Fleischer AB Jr
    United States Burden of Melanoma and Non-Melanoma Skin Cancer from 1990 to 2019.
    J Am Acad Dermatol. 2021 Apr 11. pii: S0190-9622(21)00755.
    >> Share

  232. OLAMIJU B, Suozzi KC, Leffell DJ, Christensen SR, et al
    Clinical Factors Impacting Clear Margins of Primary Melanoma in Situ with Conventional Excision in a Retrospective Cohort.
    J Am Acad Dermatol. 2021 Apr 10. pii: S0190-9622(21)00764.
    >> Share

  233. HEYMANN WR
    Melanoma Healthcare and Outcome Disparities: You Can Never Be Too Rich or Too Thin.
    J Am Acad Dermatol. 2021 Apr 3. pii: S0190-9622(21)00679.
    >> Share

  234. LUKOWIAK TM, Perz AM, Aizman L, Kovell RC, et al
    Mohs micrographic surgery for male genital tumors: Local recurrence rates and patient-reported outcomes.
    J Am Acad Dermatol. 2021;84:1030-1036.
    >> Share

  235. WILLIAMS EA, Shah N, Danziger N, Montesion M, et al
    Clinical, histopathologic, and molecular profiles of PRKAR1A-inactivated melanocytic neoplasms.
    J Am Acad Dermatol. 2021;84:1069-1071.
    >> Share

  236. MURZAKU EC, Shi K, Srivastava D, Nijhawan RI, et al
    Surgical management and practices in pregnancy and lactation: A survey of United States dermatologic surgeons.
    J Am Acad Dermatol. 2021;84:1134-1136.
    >> Share

  237. EASON CD, Rundle C, Dunnick CA, Hugh J, et al
    National trends in free public sunscreen dispensers.
    J Am Acad Dermatol. 2021;84:1109-1111.
    >> Share

    March 2021
  238. BAYERS S, Orseth M, Prasad S, Hynan LS, et al
    Community-based melanoma screening: A pilot study for the development of an educational curriculum for nonphysician providers.
    J Am Acad Dermatol. 2021 Mar 29. pii: S0190-9622(21)00362.
    >> Share

  239. THOMPSON LL, Chang MS, Polyakov NJ, Blum AE, et al
    Prognostic significance of cutaneous immune-related adverse events in patients with melanoma and other cancers on immune checkpoint inhibitors.
    J Am Acad Dermatol. 2021 Mar 12. pii: S0190-9622(21)00563.
    >> Share

  240. CULLISON CR, Tripathi R, Bordeaux JS
    Identifying sociodemographic factors associated with hospitalization following primary excision of cutaneous melanoma.
    J Am Acad Dermatol. 2021 Mar 2. pii: S0190-9622(21)00466.
    >> Share

  241. PITNEY T, Muir DJ
    Single-center, single-operator, retrospective analysis of base transection rates in shave procedures for melanoma diagnosis.
    J Am Acad Dermatol. 2021;84:861-862.
    >> Share

  242. MILLER RC, Stewart CR, Lipner SR
    Retrospective study of trends in dermatology telemedicine and in-person visits at an academic center during COVID-19.
    J Am Acad Dermatol. 2021;84:777-779.
    >> Share

    February 2021
  243. KOBLINSKI JE, Maykowski P, Zeitouni NC
    Disparities in melanoma stage at diagnosis in Arizona: A 10-Year Arizona Cancer Registry Study.
    J Am Acad Dermatol. 2021 Feb 20. pii: S0190-9622(21)00404.
    >> Share

  244. GILLSTEDT M, Hedlund E, Paoli J, Polesie S, et al
    Discrimination between Invasive and In situ Melanomas Using a Convolutional Neural Network.
    J Am Acad Dermatol. 2021 Feb 12. pii: S0190-9622(21)00336.
    >> Share

  245. BRINKER TJ, Schmitt M, Krieghoff-Henning EI, Barnhill R, et al
    Diagnostic performance of artificial intelligence for histologic melanoma recognition compared to 18 international expert pathologists.
    J Am Acad Dermatol. 2021 Feb 10. pii: S0190-9622(21)00331.
    >> Share

  246. GONZALEZ-CAO M, Carrera C, Rodriguez Moreno JF, Rodriguez-Jimenez P, et al
    COVID-19 in Melanoma Patients: Results of the Spanish Melanoma Group Registry, GRAVID study.
    J Am Acad Dermatol. 2021 Feb 10. pii: S0190-9622(21)00337.
    >> Share

  247. STRAKER RJ 3RD, Song Y, Shannon AB, Chu EY, et al
    Association of the Affordable Care Act's Medicaid Expansion with the diagnosis and treatment of clinically localized melanoma: A National Cancer Database Study.
    J Am Acad Dermatol. 2021 Feb 4. pii: S0190-9622(21)00308.
    >> Share

  248. VOGEL RI, Jewett PI, Ahmed RL, Lazovich D, et al
    Comparison of sun exposure and protection behaviors between urban and rural residents without a history of melanoma in the Midwestern United States.
    J Am Acad Dermatol. 2021 Feb 3. pii: S0190-9622(21)00304.
    >> Share

  249. LALLAS A, Lallas K, Tschandl P, Kittler H, et al
    The dermoscopic inverse approach significantly improves the accuracy of human readers for lentigo maligna diagnosis.
    J Am Acad Dermatol. 2021;84:381-389.
    >> Share

    January 2021
  250. POLESIE S, Gillstedt M
    Psoriasis and risk of cutaneous melanoma: a retrospective comparative registry-based cohort study.
    J Am Acad Dermatol. 2021 Jan 30. pii: S0190-9622(21)00244.
    >> Share

  251. SCHWAB G, Gerami P, Fiessinger L, Nardone B, et al
    A comparison of the Breslow depth and all-cause survival of male and female genital melanomas.
    J Am Acad Dermatol. 2021 Jan 28. pii: S0190-9622(21)00216.
    >> Share

  252. TAN A, Greenwald E, Bajaj S, Belen D, et al
    Melanoma surveillance for high-risk patients via telemedicine: Examination of real-world data from an integrated store-and-forward total body photography and dermoscopy service.
    J Am Acad Dermatol. 2021 Jan 27. pii: S0190-9622(21)00206.
    >> Share

  253. NADELMAN DA, Ahn JW, VanKoevering KK, Smith NR, et al
    Research Letter: A Single Institution's Review of Patterns of Compliance with Melanoma Ultrasound Surveillance Recommendations.
    J Am Acad Dermatol. 2021 Jan 25. pii: S0190-9622(21)00225.
    >> Share

  254. HU X, Kilgour JM, Fogel AL, Jia JL, et al
    Direct-to-Consumer Genetic Risk Scoring for Melanoma Improves Adherence to Sun-Protective Behaviors Among Increased-Risk Groups: Results from a Prospective U.S. Cohort Study.
    J Am Acad Dermatol. 2021 Jan 18. pii: S0190-9622(21)00191.
    >> Share

  255. VARGAS-MORA P, Peruilh-Bagolini L, Gonzalez-Cuevas R, Ferrer-Rosende P, et al
    Impact of the time interval between primary melanoma excision and sentinel node biopsy: A systematic review and meta-analysis.
    J Am Acad Dermatol. 2021 Jan 16. pii: S0190-9622(21)00162.
    >> Share

  256. BHATT MD, Perz AM, Moioli E, Sobanko JF, et al
    The accuracy of detecting melanoma on frozen section MART-1 stains and on permanent sections of previously-frozen tissue: a prospective cohort study.
    J Am Acad Dermatol. 2021 Jan 13. pii: S0190-9622(21)00008.
    >> Share

  257. WEI C, Allais B, Tornberg HN, Quan T, et al
    The utilization of the Altmetric and PlumX scores in evaluating the top 100 trending melanoma articles in social media.
    J Am Acad Dermatol. 2021 Jan 8. pii: S0190-9622(21)00084.
    >> Share

  258. MARSON JW, Maner BS, Harding TP, Meisenheimer J VII, et al
    The Magnitude of COVID-19's Effect on the Timely Management of Melanoma and Non-Melanoma Skin Cancers.
    J Am Acad Dermatol. 2021 Jan 8. pii: S0190-9622(21)00082.
    >> Share

  259. HARTMAN RI, La J, Chang MS, Cheng D, et al
    Risk factors for thick melanoma among Veterans: A cross-sectional study.
    J Am Acad Dermatol. 2021 Jan 7. pii: S0190-9622(21)00086.
    >> Share

  260. MOUSTAFA D, Duncan LM, Hawryluk EB
    A 20-year histopathologic study of pediatric nevi at an academic institution.
    J Am Acad Dermatol. 2021;84:39-40.
    >> Share

  261. LEWINSON RT, Meyers DE, Vallerand IA, Suo A, et al
    Machine learning for prediction of cutaneous adverse events in patients receiving anti-PD-1 immunotherapy.
    J Am Acad Dermatol. 2021;84:183-185.
    >> Share

  262. NAVARRETE-DECHENT C, Liopyris K, Monnier J, Aleissa S, et al
    Reflectance confocal microscopy terminology glossary for melanocytic skin lesions: A systematic review.
    J Am Acad Dermatol. 2021;84:102-119.
    >> Share

    December 2020
  263. SHANNON AB, Sharon CE, Straker RJ 3rd, Miura JT, et al
    The Impact of the COVID-19 Pandemic on the Presentation Status of Newly Diagnosed Melanoma: A Single Institution Experience.
    J Am Acad Dermatol. 2020 Dec 19. pii: S0190-9622(20)33225.
    >> Share

  264. MIGUEL BAF, Morgado-Carrasco D, Toll A, Perez-Anker J, et al
    Meshed keystone flap: A last-step modification to reduce tension and cover a larger surface.
    J Am Acad Dermatol. 2020;83:e397-e398.
    >> Share

    November 2020
  265. DIKA E, Mastroeni S, Lambertini M, Scarfi F, et al
    The chronic use of multiple photosensitizing drugs is associated with Breslow thickness in female melanoma patients: A bicentric retrospective study.
    J Am Acad Dermatol. 2020 Nov 27. pii: S0190-9622(20)33097.
    >> Share

  266. ALLAIS BS, Beatson M, Wang H, Shahbazi S, et al
    Five-Year Survival in Patients with Nodular and Superficial Spreading Melanomas in the US Population.
    J Am Acad Dermatol. 2020 Nov 27. pii: S0190-9622(20)33094.
    >> Share

  267. BARRIOS DM, Do MH, Phillips GS, Postow MA, et al
    Immune checkpoint inhibitors to treat cutaneous malignancies.
    J Am Acad Dermatol. 2020;83:1239-1253.
    >> Share

    October 2020
  268. BEHBAHANI S, Malerba S, Maniar A, Taback B, et al
    Outcomes and Predictors of Survival in Cutaneous Melanoma of the Eyelid: An Analysis of the National Cancer Database.
    J Am Acad Dermatol. 2020 Oct 31. pii: S0190-9622(20)32903.
    >> Share

  269. KELM RC, Ali Y, Orrell K, Rangel SM, et al
    Age and sex differences for malignant melanoma in the pediatric population-childhood versus adolescence: analysis of current nationwide data from the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) program.
    J Am Acad Dermatol. 2020 Oct 24. pii: S0190-9622(20)32862.
    >> Share

  270. NAVARRETE-DECHENT C, Aleissa S, Connolly K, Hibler BP, et al
    Clinical size is a poor predictor of invasion in melanoma of the lentigo maligna type.
    J Am Acad Dermatol. 2020 Oct 20. pii: S0190-9622(20)32835.
    >> Share

  271. SISCOS SM, Neill BC, Seger EW, Rajpara A, et al
    Practice habits of Mohs surgeons treating melanoma with Mohs surgery: a cross-sectional survey.
    J Am Acad Dermatol. 2020 Oct 3. pii: S0190-9622(20)32682.
    >> Share

  272. SHI K, Kim D, Mohan LS, Garfield EM, et al
    A retrospective cohort study of the diagnostic value of different subtypes of atypical pigment network on dermoscopy.
    J Am Acad Dermatol. 2020;83:1028-1034.
    >> Share

  273. KINSER K, Barlow CE, Leonard D, Farrell SW, et al
    Tanning bed use and depression in a preventive medicine cohort: The Cooper Center Longitudinal Study.
    J Am Acad Dermatol. 2020;83:1200-1202.
    >> Share

  274. YELAMOS O, Manubens E, Jain M, Chavez-Bourgeois M, et al
    Improvement of diagnostic confidence and management of equivocal skin lesions by integration of reflectance confocal microscopy in daily practice: Prospective study in 2 referral skin cancer centers.
    J Am Acad Dermatol. 2020;83:1057-1063.
    >> Share

    July 2020
  275. SOLEYMANI T, Swetter SM, Hollmig ST, Aasi SZ, et al
    Adequacy of conservative 2- to 3-mm surgical margins for complete excision of biopsy-proven severely dysplastic nevi: Retrospective case series at a tertiary academic institution.
    J Am Acad Dermatol. 2020;83:254-255.
    >> Share

    June 2020
  276. JAFRY MA, Peacock S, Radick AC, Shucard HL, et al
    Pathologists' agreement on treatment suggestions for melanocytic skin lesions.
    J Am Acad Dermatol. 2020;82:1435-1444.
    >> Share

    May 2020
  277. PEREZ-ANKER J, Puig S, Malvehy J
    A fast and effective option for tissue flattening: Optimizing time and efficacy in ex vivo confocal microscopy.
    J Am Acad Dermatol. 2020;82:e157-e158.
    >> Share

    April 2020
  278. FRIEDMAN BJ, Lee JB
    Spitz nevi in older adults: Correlation of histopathology with results of a gene expression profiling assay.
    J Am Acad Dermatol. 2020;82:1021-1023.
    >> Share

  279. BATCHELDER E, Straight C, Butt M, Kirby JS, et al
    Information framing effects on patients' decisions about dysplastic nevus management.
    J Am Acad Dermatol. 2020;82:1011-1013.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016